AI and biotech leaders urge US Congress to regulate synthetic DNA sales over bioweapon concerns
By
Marta Iraola Iribarren
Summary
CEOs from major AI companies (OpenAI, Anthropic, Microsoft AI, Google DeepMind) have joined with biotechnology experts in urging the US Congress to pass laws requiring safety screenings for synthetic DNA purchases. While synthetic DNA has beneficial uses like vaccine development, it also poses risks of being used to create bioweapons. The letter targets US lawmakers but highlights global implications since synthetic DNA can be ordered and shipped worldwide.
Source
Key quotes
· 3 pulledThe CEOs of some of the biggest artificial intelligence (AI) companies, including OpenAI, Anthropic, Microsoft AI and Google DeepMind have teamed up with biotechnology experts to urge the United States to pass laws requiring safety screenings of synthetic DNA purchases.
Synthetic DNA refers to artificially manufactured genetic material, which can be custom-made by companies and ordered online, and delivered like any other laboratory supply.
The letter is directed at the US Congress, but the issue has global implications as the material can be ordered and shipped worldwide.
You might also wanna read

AI industry leaders unite to urge US lawmakers on bioweapon safeguards
AI industry rivals including Anthropic's Dario Amodei, OpenAI's Sam Altman, and Microsoft's Mustafa Suleyman have united in an open letter t

AI industry leaders unite to urge US lawmakers on bioweapon safeguards
AI industry rivals including Anthropic's Dario Amodei, OpenAI's Sam Altman, and Microsoft's Mustafa Suleyman have united in an open letter t
Untitled
U.S. Export Controls on Anthropic's AI Models Raise Concerns Over Innovation and Governance
The article discusses the U.S. government's use of export control authority to restrict access to Anthropic's latest AI models, warning that

STAT+: I spoke to Anthropic’s CEO about how AI may affect biotech. Here’s what I learned
U.S. Bans Anthropic AI as National Security Risk, OpenAI Secures Pentagon Deal
The article reports on President Trump ordering the U.S. government to stop using Anthropic's AI products and the Pentagon designating the c
U.S. restrictions on Chinese biotech could harm patients, argues editorial
The article argues against U.S. efforts to restrict collaboration with China's biotechnology industry, framing it as an extension of the tec
U.S. restrictions on Chinese biotech could harm patients, argues editorial
The article argues against U.S. efforts to restrict collaboration with China's biotechnology industry, framing it as an extension of the tec

Comments
Sign in to join the conversation.
No comments yet. Be the first.